PCR-RFLP Detection and Typisation of Human Papillomaviruses (HPVs)
DOI:
https://doi.org/10.5644/Radovi.359Keywords:
HPVs, PCR, RFLPAbstract
Human papillomaviruses (HPV) are the members of the family Papovaviridae. Viral particles are spherical, with icosahedral symmetry, 55 nm in diameter, containing double strand molecule of DNA (mol. weight 8xl03). HPV cause benign and malignant lesions of epithelial and mucous tissue. On the basis of epidemiological and experimental data it is
known that HPV is the main etiological causative agent of cervix cancer which can be transmitted sexual contact. This virus has very unstable genome which mutates very often. At present, there are more than 70 different HPV types divided into three following groups:
HPVs of low oncogenic risk (types 6 and 7);
HPVs of intermediate oncogenic risk (types 31, 35 and 45);
HPVs of high oncogenic risk (types 16, 18 and 33).
It is very important in therapeutical and preventive sense early detection of HPV and corresponding typization. Now it is possible to achieve this by combination of two molecular methods such as PCR (Polymerase Chain Reactiori) and RFLP (Restriction Fragment Length Polymorphisni) which are adapted for analyzing of L1-region HPV-DNA (1, 2, 3).
We analyzed total 123 specimens by HPV-DNA-PCR (Ll-ORF) method (41 cervix specimens, 41 urine-superatant and 41 urine-pellet specimens). Samples detected as positive (4, 5, 28, 33, 38, 39 and 40) in all PCR analysis are typed by RFLP.
Out of 16 HPV-DNA-PCR positive specimens analyzed by RFLP detected HPV types were: 6, 2a, 16, 33 and 10a.
The percentage of successful typization of HPVs by RFLP was 40%. For five specimens after RFLP analysis, electrophoretic patterns were unclear. These PCR products and other which showed undefined restriction fragments must be controlled and confirmed by sequencing method.
References
Manos, M.M. Ting, Y., Wright, D.K. Levvis, A.J., Broker, T.R., Walinsky, S.M., 1989: Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells, 7, 209 — 214.
Forslund, O., Hansson, B.G., Rymark, P. and Bjerre, B., 1993: Human papillomavirus DNA in urine samples compared to that in simultaneously collected urethra and cervix samples. J. clin. Microbiol.31, 1975 - 1979.
Cartvvright, N.C., Sant Cassia, L.J., Easton, A.J., and Morris, A.G., 1996: Detection of human papillomavirus in vulal carcinoma using seminested PCR and restriction enzyme typing: a rapid and sensitive technique. J.Clin.Pathol: Mol.Pathol.49,236 - 239.
Gissman, L., Wolnik, H., Ikenberg, H., Koldovsky, V., Schnurch, G.H. and Zur Hausen, H., 1983: Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc. Natl. Acad. Sci. SA 80, 560 - 563.
Boshart, M., Gissman, L., Ikenberg, H., Kleinheinz, A., Scheurlen, W., Zur Hausen. H., 1984: A new type of papillomavirus DNA its presence in genital cancer diopsies and in cell lines derived from cervical cancer. EMBO J., 3, 1151 - 1157.
Koutsky, L.D., Galloway, D.A., and Holmes, K.K., 1988: Epidemiology of genital human papillomavirus infection. Epidemiologic Reviews 10, 123 - 163.
Van der Brule, A.J.C., Walboomers, du Maine, M., Kenemans, P., and Meijer, C.J.L.M., 1991: Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int. J. Cancer. 48, 404-408.
Lungu, O., Sun, X.W., Felix, J., Richart, R.M., Silvestern, S. And Wright, T.C., 1992: Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. Int. J. Cancer. 48, 404-408.
Singleton, P. and Sainbury, D., 1993: Dictionary of microbiology and molecular biology. Second Edition. A Wiley Interscience Publication-Wiley and Sons.
Gissman, L. and Zur Hausen, H., 1980: Partial characterization of viral DNA from genital warts (Condyloma accuminatum). International Journal of Cancer. 25, 605 - 609.
Brooks, F.G., Butel, V.S. and Morse, S. A., 1998.; Medical microbiology. Appleton and Longe England. 326 - 546.
Crum, C.P.,Mitao, M., Levine, R.V. and Silverstein, S., 1985: Cervical papillomaviruses segregate within morphologically distine precancerous lesions. Journal of virology 54, 675 - 681.
Gray, J., Strauss, S. and Desselberger, V., 1997: Human papillomavirus PHLS Reference Laboratory. First interim report. Cambridge, England.
Ting, Y. And Manos, M.M., 1990: Detection and typing of genital human papillomaviruses. In PCR protocols: A guide to methods and applications (Gelfand, M.M Sninsky, J. and White T. Eds) 356-367. San Dicgo, CA-Academic Press Ine.
Lungu, O., Wright, T.C. and Silvestern, S., 1992: Typing human papillomaviruses by polymerase chain reaction amplification with LI consensus primers and RFLP analysis. Mol. Cell. Probes 6, 145-152.
Stewart, M., Gravitt, E., Cheng, S. And Whecler, M., 1996: Generation of entire human papillomavirus genome by Long PCR Frequency of errors produced during amplification. Genome researeh. Volume 5. Number 1. 79-87.
Hernandez-Avila, M., Lazcano-Ponce, E.C., Berumen-Campos, J., Cruz-Valdez, A., Alonso de Ruiz, P.P., Gonzalez-Lira, G., 1997: Human papillomavirus 16-18 infection and cervical cancer in Mexico: a case-control study. Arch. Med. Res. 28 (2): 256-71.
Chabaud, M., Le Cann, P., Mayelo, V., Loboulleux, D., Diallo, A.S., Enogat, N., Afoutou, J.M., Anthonioz, P., Coll-Seck, A.M., Coursaget, P., 1996: Detection by PCR of human papillomavirus genotypes in cervical lesions of Senegalese women. J. Med. Virol. 49 (4): 259-63.
Glooen, K., Plsen, A.O., Magnus, P., Grinde, B., Sauer, T., Orstavik, L, 1996: Prevalence of human papillomavirus in cervical serapes, as analyzed by PCR, in a population-based sample of women with and without cervical dysplasia. APMIS 104 (1): 68-74.
Yadav, M., Nurhayati, Z.A., Padmanathan, A., Abdul Aziz, Y., Norhanom, A.W., 1995: Polymerase chain reaction detection and restriction enzyme typing of human papillomavirus in cervical carcinoma. Med. J. Malaysia 50(1): 64-71.
Bosch, F.X., Manos, M.M., Munoz, N., Sherman, M., Jansen, A.M., Schiffman, M.H., Moreno, V., Kurman, R., Shah, K.V., 1995: Prevalence of human papillomavirus in cervical cancer: a world-wide perspective. International biological study on cervical cancer (1BSCC) Study Group. J. Natl. Cancer Inst. 87 (11): 796-802.
Karaloglu, D., Yazici, H., Alatli, C., Yaman, F., Aslay, I., On at, H., Dalay, H., 1996: Detection of HPV16 and HPV 18 infection in patients with cervical neoplasia. Eur. J. Gynaecol. Oncol. 17 (4): 296-8.
Chen, C.M., Shyu, M.P., Au, L.C., Chu, H.W., Cheng, W.T., Choo, K.B., 1994: Analysis ofdeletion of the integrated human papillomavirus 16 sequence in cervical cancer: a rapid multiplex polymerase chain reaction approach. J. Med. Virol. 44 (2): 206-11.
Donaldson, Y.K., Arends, M.J., Duvall, E., Bird, C.C., 1993: A PCR approach to discriminate between integrated and episomal HPVDNA in small clinical specimens. Mol. Cell. Probes 7 (4): 285 - 92.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Đemo Subašić, Muhamed Čurić, Irma Salimović, Kemal Šerić

This work is licensed under a Creative Commons Attribution 4.0 International License.


